BRCA1 mutation carriers develop breast and ovarian cancer at a younger age than BRCA2 mutation carriers, and BRCA2 is associated with fewer cases of breast cancer than BRCA1 [15]. Here, BRCA2 is linked to ovarian carcinoma.